Kaya Holdings, Inc (OTCQB:KAYS) is a mind care company focusing on wellness and mental health through operations in medical and recreational cannabis, CBD products and psychedelic treatment clinics.

KAYS has the historical distinction of being the first U.S. publicly traded company to hold and operate cannabis licenses in “touch the plant” categories when it commenced cannabis operations in Portland, Oregon in 2014.

In 2018, frustrated with elusive federal legalization, and after operating cultivation and processing facilities, building a strong retail brand, developing consumer brands in smokable, extracted, and infused categories, and establishing an extensive genetic library, management elected to leverage its experience in more inviting markets. Today KAYS has two Greek licenses and an Israeli license, with its first Greek project under development.

And now, as we approach the advent of the medical psychedelic market we are again among the innovators, with 9 years of cannabis experience to fortify us as we move to open one of the first state licensed Psilocybin Treatment Centers in the United States in Portland, Oregon. Whether cannabis or psychedelics, our team is motivated by, and dedicated to, providing relief from debilitating, treatment resistant mental health conditions like depression, PTSD, eating
disorders, and addiction through emerging legal alternative remedies.